NVO ์ต์ ๋ถ๊ธฐ ์์ต
๋ฐํ ๋ ์ง8/4/2026
EPS ์ค์ (๋ฏธ๊ตญ ๋ฌ๋ฌ)0.74
์์ต ์ค์ (๋ฏธ๊ตญ ๋ฌ๋ฌ)12.21B
Novo Nordisk A/S ์ค์ ๋ฐํ ๋ ์ง ๋ฐ ๋ณด๊ณ ์
์ด ํ์ด์ง๋ ์ต์ Novo Nordisk A/S ์์ต ๋ณด๊ณ ์, ๋ค๊ฐ์ค๋ Novo Nordisk A/S ์ค์ ๋ฐํ ๋ ์ง, ๊ณผ๊ฑฐ ๋ฐ์ดํฐ ๋ฐ Novo Nordisk A/S ์ค์ ๋ฐํ ์ปจํผ๋ฐ์ค ๋ด์ค๋ฅผ ํฌํจํ ์์ธํ Novo Nordisk A/S ์์ต ๋ฐ์ดํฐ๋ฅผ ์ ๊ณตํฉ๋๋ค.
NVO ํฅํ ๋ถ๊ธฐ ์ค์
๋ฐํ ๋ ์ง--
EPS ์์(๋ฏธ๊ตญ ๋ฌ๋ฌ)--
์์ต ์์(๋ฏธ๊ตญ ๋ฌ๋ฌ)--
NVO FY2025 ์์ต
์ฐ๊ฐ ์ฃผ๋น์์ด์ต ์ฑ์ฅ๋ฅ (YoY)3.485.93%
์ฐ๊ฐ ๋งค์ถ ์ฑ์ฅ๋ฅ (YoY)46.70B10.88%
Novo Nordisk A/S(NVO) ์ค์ ๋ด์ญ
| ๋ฐํ์ผ | ๊ธฐ๊ฐ ์ข ๋ฃ | EPS/์์ | ์์ต/์์ | EPS ์ํ๋ผ์ด์ฆ % | ์์ต ์ํ๋ผ์ด์ฆ % |
|---|---|---|---|---|---|
| 8/4/2026 | 06/2026 | 0.74/0.77 | 12.21B/11.16B | -5.06% | 9.36% |
| 5/6/2026 | 03/2026 | 1.71/0.95 | 15.17B/11.33B | 79.65% | 33.86% |
| 2/3/2026 | 12/2025 | 0.94/0.89 | 12.34B/12.09B | 5.82% | 2.03% |
| 11/5/2025 | 09/2025 | 0.71/0.71 | 11.74B/12.12B | -1.02% | -3.10% |
| 8/6/2025 | 06/2025 | 0.91/0.92 | 11.67B/11.79B | -1.43% | -1.02% |
| 5/7/2025 | 03/2025 | 0.92/0.96 | 11.01B/12.25B | -3.80% | -10.13% |
| 2/5/2025 | 12/2024 | 0.91/0.91 | 12.25B/12.40B | -0.42% | -1.17% |
| 11/6/2024 | 09/2024 | 0.90/0.93 | 10.50B/11.05B | -2.80% | -4.91% |